The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression

Advances in Medical Sciences

Volumn 59, Issue 2, 2014, Pages 221-226

  Jurkowska, Grazyna ^a   Piotrowska Staworko, Grazyna ^b   Guzińska Ustymowicz, Katarzyna ^a   Kemona, Andrzej ^a   ͆widnicka Siergiejko, Agnieszka ^a   Łaszewicz, Wiktor ^b   Da¸browski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Hospital   (Poland)

Author keywords

c erB 2 protein; Epidermal growth factor; Epidermal growth factor receptor; Helicobacter pylori infection

Indexed keywords

AMOXICILLIN; C ERB 2 PROTEIN; CLARITHROMYCIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GASTRIN; OMEPRAZOLE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL CLEARANCE; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; GASTRIN BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; PROTEIN EXPRESSION; STOMACH ANTRUM; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

EID: 84908460864     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2014.01.006     Document Type: Article

References (34)

1. Peek Jr RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006;208(January (2)):233-48.
2. Ernst PB, Crowse SE, Reyers VE. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastronterology 1997;113(December (6 Suppl.)):S35-42.
3. Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, Perez-Perez GI, et al. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains. Cancer Res 2001;61(February (4)):1406-11.
4. Axon AT. Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion. Adv Med Sci 2007;52:55-60.
5. Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, et al. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Anticancer Res 1998;18(July-August (4A)):2727-32.
6. Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis. Cancer Sci 2011;102(April (4)):713-9.
7. Garcia I, Vizoso F, Martin A, Sanz L, Abdel-Lah O, Raigoso P, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in respectable gastric cancer. Ann Surg Oncol 2003;10(April (3)):234-41.
8. Mammano E, Belluco C, Sciro M, Mencarelli R, Agostini M, Michelotto M, et al. Epidermal growth factor receptor (EGFR); mutational and protein expression analysis in gastric cancer. Anticancer Res 2006;26(September-October (5A)):3547-50.
9. Wang YL, Sheu BS, Yang HB, Lin PW, Chang YC. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma-emphasis on its relation to H. pylori infection and clinicohistological characteristics. Hepatogastroenterology 2002;49(July-August (46)):1172-6.
10. Garcia I, Vizoso F, Andicoechea A, Fernandez P, Suarez C, García-Muñz JL, et al. C-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa. Int J Biol Marker 2000;15(July-September (3)):231-4.
11. Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, et al. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Hepatogastroenterology 1997;44(March-April (14)):604-9.
12. Dan L, Jian D, Na L, Xiaozhong W. Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901. Onco Targets Ther 2012;5(October (23)):271-7.
13. Sarosiek J, Bliski J, Mutry VL, Slomiany A, Slomiany BL. Role of salivary epidermal growth factor in the maintenance of physicochemical characteristic of oral and gastric mucosal mucus coat. Biochem Biophys Rec Commun 1988;152(May (3)):1421-7.
14. Konturek JW, Brzozowski T, Konturek SJ, Bielanski W, Faller G, Kirchner T, et al. Epidermal growth factor and transforming growth factor alfa in duodenal ulcer and non-ulcer dyspepsia patients before and after H. pylori eradication. Scand J Gastroenterol 1998;33(February (2)):143-51.
15. Coyle WJ, Sedlack RE, Nemec R, Peterson R, Duntemann T, Murphy M, et al. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Am J Gastroenterol 1999;94(October (10)):2885-9.
16. Wong B, Wang W, So W, Shin VY, Wong WM, Fung FM, et al. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment Pharmacol Ther 2001;15(September (9)):1459-65.
17. Schiemann U, Konturek J, Assert R, Rembiasz K, Domschke W, Konturek S. Pfeiffer A. mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication. Med Sci Monit 2002;8(February (2)):CR53-8.
18. Dickson JH, Grabowska A, El-Zaatari M, Atherton J, Watson SA. Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor. Cancer Res 2006;66(August (15)):7524-31.
19. Keates S, Keates AC, Katchar K, Peek Jr RM, Kelly CP. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis 2007;196(July (1)):95-103.
20. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, et al. Epidermal growth factor receptor activation protects gastrc epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 2009;136(April (4)):1297-307. e1-3.
21. Dixon MF, Path FRC, Genta RM, Corre P. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20(October (10)):1161-81.
22. Gray SF, Wyatt JI, Rathbone BJ. Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol 1986;39(November (11)):1279.
23. Jaehne J, Urmacher C, Thaler HT, Friedlander-Klar H, Cordon-Cardo C, Meyer HJ. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. J Cancer Res Clin Oncol 1992;118(6):474-9.
24. Maciorkowska E, Guzińska-Ustymowicz K, Ryszczuk E, Kemona A, Kaczmarski M, The EGFR. expression in gastric mucosa of children infected with Helicobacter pylori. Adv Med Sci 2009;54(December (2)):187-93.
25. Maciorkowska E, Marcinkiewicz S, Kaczmarski M, Kemona A. Inflammatory changes of the gastric mucosa and serum concentration of chosen growth factors in children. Adv Med Sci 2010;55(June (1)):59-66.
26. Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 2006;51(August (8)):1371-9.
27. Matsui Y, Inomata M, Tojigamori M, Sonoda K, Shiraishi N, Kitano S. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER 2 antibody in a murine model. Int J Oncol 2005;27(September (3)):681-5.
28. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999;85(May (9)):1894-902.
29. Wang J, Chi DS, Kalin GB, Sosinski C, Miller LE, Burja I, et al. H. pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci 2002;47(January (1)):107-13.
30. Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16(March (3)):515-20.
31. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101(July (1)):167-74.
32. Bechi P, Balzi M, Becciolini A, Maugeri A, Raggi CC, Amorosi A, et al. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol 1996;91(February (2)):271-6.
33. Anti M, Armuzzi A, Gasbarrini A, Gasbarrini G. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut 1998;43(July (Suppl. 1)):S27-32.
34. De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, et al. Current status of targeted therapies in advanced gastric cancer. Expert Opin Ther Targets 2012;16(April (2)):S29-34.